Instituto de Ciencias e Innovación en Medicina, Facultad de Medicina Clínica Alemana Universidad del Desarrollo, Santiago, Chile.
Advanced Center for Chronic Diseases (ACCDiS), Santiago, Chile.
Clin Infect Dis. 2023 Jul 5;77(Suppl 1):S75-S81. doi: 10.1093/cid/ciad283.
Antimicrobial resistance is a global threat, heavily impacting low- and middle-income countries. This study estimated antimicrobial-resistant gram-negative bacteria (GNB) fecal colonization prevalence in hospitalized and community-dwelling adults in Chile before the coronavirus disease 2019 pandemic.
From December 2018 to May 2019, we enrolled hospitalized adults in 4 public hospitals and community dwellers from central Chile, who provided fecal specimens and epidemiological information. Samples were plated onto MacConkey agar with ciprofloxacin or ceftazidime added. All recovered morphotypes were identified and characterized according to the following phenotypes: fluoroquinolone-resistant (FQR), extended-spectrum cephalosporin-resistant (ESCR), carbapenem-resistant (CR), or multidrug-resistant (MDR; as per Centers for Disease Control and Prevention criteria) GNB. Categories were not mutually exclusive.
A total of 775 hospitalized adults and 357 community dwellers were enrolled. Among hospitalized subjects, the prevalence of colonization with FQR, ESCR, CR, or MDR-GNB was 46.4% (95% confidence interval [CI], 42.9-50.0), 41.2% (95% CI, 37.7-44.6), 14.5% (95% CI, 12.0-16.9), and 26.3% (95% CI, 23.2-29.4). In the community, the prevalence of FQR, ESCR, CR, and MDR-GNB colonization was 39.5% (95% CI, 34.4-44.6), 28.9% (95% CI, 24.2-33.6), 5.6% (95% CI, 3.2-8.0), and 4.8% (95% CI, 2.6-7.0), respectively.
A high burden of antimicrobial-resistant GNB colonization was observed in this sample of hospitalized and community-dwelling adults, suggesting that the community is a relevant source of antibiotic resistance. Efforts are needed to understand the relatedness between resistant strains circulating in the community and hospitals.
抗微生物药物耐药性是一个全球性威胁,严重影响中低收入国家。本研究在 2019 年冠状病毒病大流行之前,估计了智利住院和社区成年人群中耐抗生素革兰氏阴性菌(GNB)粪便定植的流行率。
2018 年 12 月至 2019 年 5 月,我们招募了智利中部 4 家公立医院的住院成年患者和社区居民,他们提供了粪便标本和流行病学信息。将样本接种到含有环丙沙星或头孢他啶的 MacConkey 琼脂平板上。根据以下表型对所有回收的形态进行鉴定和特征描述:氟喹诺酮耐药(FQR)、广谱头孢菌素耐药(ESCR)、碳青霉烯耐药(CR)或多重耐药(MDR;根据疾病控制和预防中心的标准)GNB。类别并非互斥。
共纳入 775 名住院成年患者和 357 名社区居民。在住院患者中,FQR、ESCR、CR 或 MDR-GNB 定植的流行率为 46.4%(95%置信区间[CI],42.9-50.0)、41.2%(95% CI,37.7-44.6)、14.5%(95% CI,12.0-16.9)和 26.3%(95% CI,23.2-29.4)。在社区中,FQR、ESCR、CR 和 MDR-GNB 定植的流行率分别为 39.5%(95% CI,34.4-44.6)、28.9%(95% CI,24.2-33.6)、5.6%(95% CI,3.2-8.0)和 4.8%(95% CI,2.6-7.0)。
在该住院和社区成年人群的样本中观察到了大量耐抗生素 GNB 定植,这表明社区是抗生素耐药的一个重要来源。需要努力了解社区和医院中循环的耐药菌株之间的相关性。